During HLTH, I spoke with some investors and digital health executives about the types of startups that they haven't encountered yet — but would like to.
Archon Biosciences' antibody cages change the structure of an antibody to control how a drug distributes in the body. The startup comes from the lab of David Baker, the University of Washington professor of biochemistry recently awarded the Nobel Prize in Chemistry for his work in computational protein design.
In a recent interview, Elizabeth Mitchell, president and CEO of the Purchaser Business Group on Health, discussed employers' challenges in accessing medical data, emphasizing the need for transparency and potential strategies to enhance their fiduciary responsibilities.
As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers.
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher.
How do you know if you're spending too much or too little on Telemedicine software? This guide from Software Advice breaks down upfront, subscription and hidden costs, plus answers other questions you've been wondering about.
No comments